Clinical trial
mRNA Therapy to Restore Lymphatic Flow in Secondary Lymphedema
NCT07793656 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- mRNA Therapy to Restore Lymphatic Flow in Secondary Lymphedema
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- April 30, 2028
- Enrollment
- 9 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
secondary lymphedema